MedTrace Logo

Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue

NCT07102550 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-03

No results posted yet for this study

Summary

The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.

Conditions

  • Liver Transplant

Interventions

BIOLOGICAL

MiMedx AmnioFix

MiMedx Amniofix to be placed on biliary anastomosis of the recipient during living donor liver transplant.

Sponsors & Collaborators

  • Choon Hyuck David Kwon

    lead OTHER

Principal Investigators

  • Choon Hyuck D Kwon, MD, PhD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-29
Primary Completion
2027-01-31
Completion
2027-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07102550 on ClinicalTrials.gov